Gm3 synthase as a therapeutic target in microvascular...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/34 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2565676

The present invention relates to the use of an inhibitor of the expression or activity of the GM3 synthase gene for the treatment of microvascular complications of diabetes, and to a method of screening compounds useful in the treatment and/or prevention of these complications.

La présente invention concerne l'utilisation d'un inhibiteur de l'expression ou de l'activité du gène de la GM3 synthase pour le traitement de complications microvasculaires du diabète; et une méthode de criblage de composés utiles dans le traitement et/ou la prévention de ces complications.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Gm3 synthase as a therapeutic target in microvascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gm3 synthase as a therapeutic target in microvascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gm3 synthase as a therapeutic target in microvascular... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1969101

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.